Doxorubicin-Trabectedin Strategy Boosts Survival in Challenging Sarcoma

Published Date: 09 Sep 2024

Combination for leiomyosarcoma improved OS by 9 months versus doxorubicin alone

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

AI tool identifies women at high risk of interval breast cancer

2.

A computer-aided diagnostic system for improved detection of breast cancer.

3.

recognizing the mechanism by which the replication of the host cell is outperformed by the skin cancer virus.

4.

Radiation therapy for patients with breast cancer

5.

Chemoimmunotherapy Boosts Head and Neck Cancer Response


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot